Related Experiment Video
Updated: Jul 19, 2025
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.3K
Future prospects in mRNA vaccine development.
Londiwe Simphiwe Mbatha1, Jude Akinyelu2, Fiona Maiyo3
1Department of Biotechnology and Food Science, Durban University of Technology, PO Box 1334, Durban 4000, South Africa.
Biomedical Materials (Bristol, England)
|August 17, 2023
Summary
Messenger RNA (mRNA) vaccines offer a powerful alternative to traditional vaccines for infectious diseases and cancer treatment due to their ability to elicit strong immune responses with few side effects. This review details current and developing mRNA vaccines, their advancements, and future prospects.
Area of Science:
- Biotechnology
- Immunology
- Vaccinology
Background:
- Messenger RNA (mRNA) vaccine technology has rapidly advanced, presenting effective alternatives to conventional vaccines.
- mRNA vaccines stimulate targeted immune responses with a favorable safety profile, minimizing clinical side effects.
- Their application extends to both infectious disease prevention and cancer treatment modalities.
Purpose of the Study:
- To provide a comprehensive overview of current and developmental mRNA vaccines.
- To highlight recent breakthroughs and innovations in mRNA vaccine technology.
- To discuss challenges and future directions in the field of mRNA vaccine development.
Main Methods:
- Literature review of existing studies on mRNA vaccine development.
- Analysis of advancements in mRNA vaccine design and delivery systems.
- Synthesis of information on clinical trial outcomes and safety profiles.
Main Results:
- mRNA vaccines are increasingly utilized for infectious diseases and cancer therapy.
- Key advancements include improved mRNA stability, delivery vehicles, and immunogenicity.
- Challenges remain in large-scale manufacturing, cost-effectiveness, and long-term efficacy studies.
Conclusions:
- mRNA vaccines represent a significant leap in vaccinology, offering versatile therapeutic and prophylactic potential.
- Continued research and development are crucial to overcome existing challenges and fully realize the potential of mRNA technology.
- The future outlook for mRNA vaccines is promising, with potential for broader applications in medicine.
More Related Videos
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
02:31Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
02:51mRNA Stability and Gene Expression
5.6K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.6K
02:27Nonsense-mediated mRNA Decay
10.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
02:28Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
02:22Regulated mRNA Transport
6.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K